BIWEEKLY PACLITAXEL AND CISPLATIN - A PHASE-I/II STUDY IN THE FIRST-LINE TREATMENT OF METASTATIC BREAST-CANCER

被引：0
|
作者：
OREILLY, SE
GELMON, KA
机构：
来源：
SEMINARS IN ONCOLOGY | 1995年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 111
页数：3
相关论文
共 50 条
  • [1] INTERIM RESULTS OF A PHASE I/II STUDY OF BIWEEKLY PACLITAXEL AND CISPLATIN IN PATIENTS WITH METASTATIC BREAST-CANCER
    TOLCHER, AW
    GELMON, KA
    SEMINARS IN ONCOLOGY, 1995, 22 (04) : 28 - 32
  • [2] Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer
    Gelmon, KA
    OReilly, SE
    Tolcher, AW
    Campbell, C
    Bryce, C
    Ragaz, J
    Coppin, C
    Plenderleith, IH
    Ayers, D
    McDermott, B
    Nakashima, L
    Healey, D
    Onetto, N
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1185 - 1191
  • [3] Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer
    Guerrero, Antonio
    Servitja, Sonia
    Rodriguez-Lescure, Alvaro
    Calvo, Lourdes
    del Barco, Sonia
    Teresa Quintanar, Maria
    Ignacio Juarez, Jose
    Gayo, Javier
    Llombart, Antonio
    Tusquets, Ignasi
    ANTI-CANCER DRUGS, 2011, 22 (03) : 283 - 289
  • [4] Biweekly gemcitabine, doxorubicin, and paclitaxel as first-line treatment in metastatic breast cancer
    Sánchez-Rovira, P
    Jaén, A
    González, E
    Porras, I
    Dueñas, R
    Medina, B
    Mohedano, N
    Fernández, M
    Martos, M
    Lozano, A
    Carrasco, E
    ONCOLOGY-NEW YORK, 2001, 15 (02): : 44 - 47
  • [5] First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study
    Elserafi, Mostafa M.
    Zeeneldin, Ahmed A.
    Abdelsalam, Ibrahim M.
    Nassar, Hanan R.
    Moneer, Manar M.
    Buhoush, Wafa H.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2018, 30 (01) : 13 - 20
  • [6] A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer
    Gelmon, KA
    Tolcher, A
    O'Reilly, S
    Campbell, C
    Bryce, C
    Shenkier, T
    Ragaz, J
    Ayers, D
    Nakashima, L
    Rielly, S
    Dulude, H
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1247 - 1249
  • [7] Biweekly gemcitabine–paclitaxel, gemcitabine–carboplatin, or gemcitabine–cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial
    Binghe Xu
    Zefei Jiang
    Sung-Bae Kim
    Shiying Yu
    Jifeng Feng
    Artur Malzyner
    Auro del Giglio
    Hyun C. Chung
    Li Jun Shen
    Daniel Lee Kay Pen
    Breast Cancer, 2011, 18 : 203 - 212
  • [8] Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: a Pilot Phase I/II Feasibility Study
    Einbeigi, Z.
    Bergstrom, D.
    Hatschek, T.
    Malmberg, M.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2008, 2 : 533 - 538
  • [9] BIWEEKLY PACLITAXEL IN THE TREATMENT OF PATIENTS WITH METASTATIC BREAST-CANCER
    GELMON, KA
    SEMINARS IN ONCOLOGY, 1995, 22 (05) : 117 - 122
  • [10] Phase II study biweekly paclitaxel, doxorubicin and gemcitabine as first line chemotherapy for metastatic breast cancer (MBC).
    Sanchez-Rovira, P
    González, E
    Porras, I
    Jaén, A
    Medina, B
    Fernández, M
    Mohedano, N
    Lozano, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S52 - S52
12345